Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer
We report the case of a young woman with HER2-positive advanced breast cancer, arising during pregnancy, with visceral involvement at onset, treated with third line therapy with the combination lapatinib and capecitabine resulting in a nearly complete long-term tumor response . The patient had prev...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2018-06-01
|
| Series: | AboutOpen |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/55 |
| id |
doaj-7e8f6db25f974d798362799153a0aaf5 |
|---|---|
| record_format |
Article |
| spelling |
doaj-7e8f6db25f974d798362799153a0aaf52020-11-25T03:26:10ZengAboutScience SrlAboutOpen2465-26282018-06-014110.19156/abtpn.2018.0037Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancerMichela Donadio0SSD Oncologia Medica Senologica, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino (Italy) We report the case of a young woman with HER2-positive advanced breast cancer, arising during pregnancy, with visceral involvement at onset, treated with third line therapy with the combination lapatinib and capecitabine resulting in a nearly complete long-term tumor response . The patient had previously been treated with first line therapy with double block, pertuzumab and trastuzumab and, after disease progression, with T-DM1 resulting in a short-term stability of clinical status (Oncology). https://journals.aboutscience.eu/index.php/aboutopen/article/view/55LapatinibTrastuzumabPertuzumabMetastatic breast cancer |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Michela Donadio |
| spellingShingle |
Michela Donadio Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer AboutOpen Lapatinib Trastuzumab Pertuzumab Metastatic breast cancer |
| author_facet |
Michela Donadio |
| author_sort |
Michela Donadio |
| title |
Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| title_short |
Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| title_full |
Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| title_fullStr |
Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| title_full_unstemmed |
Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| title_sort |
lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer |
| publisher |
AboutScience Srl |
| series |
AboutOpen |
| issn |
2465-2628 |
| publishDate |
2018-06-01 |
| description |
We report the case of a young woman with HER2-positive advanced breast cancer, arising during pregnancy, with visceral involvement at onset, treated with third line therapy with the combination lapatinib and capecitabine resulting in a nearly complete long-term tumor response . The patient had previously been treated with first line therapy with double block, pertuzumab and trastuzumab and, after disease progression, with T-DM1 resulting in a short-term stability of clinical status (Oncology).
|
| topic |
Lapatinib Trastuzumab Pertuzumab Metastatic breast cancer |
| url |
https://journals.aboutscience.eu/index.php/aboutopen/article/view/55 |
| work_keys_str_mv |
AT micheladonadio lapatinibandcapecitabineasthirdlinetherapyinyoungwomanwithadvancedbreastcancer |
| _version_ |
1724593717316157440 |